Neoplasm of mediastinum

disease
On this page

Also known as mediastinal neoplasmmediastinal tumormediastinal tumourmediastinum neoplasmmediastinum neoplasm (disease)mediastinum tumormediastinum tumourneoplasm of the mediastinumtumor of mediastinumtumor of the mediastinumtumour of mediastinumtumour of the mediastinum

Summary

Neoplasm of mediastinum (MONDO:0021386) is a cancer (an umbrella term covering 7 Mondo subtypes) and 16 clinical trials. Top therapeutic interventions include cyclophosphamide anhydrous, doxorubicin, and betamethasone. A subtype of neoplasm of thorax — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Classification: Cancer
  • Umbrella term: 7 Mondo subtypes
  • Clinical trials: 16

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameneoplasm of mediastinum
Mondo IDMONDO:0021386
NCITC3221
SNOMED CT126725000
UMLSC0025063
MedGen44322
Anatomy (UBERON)UBERON:0003728
Is cancer (heuristic)yes

Also known as: mediastinal neoplasm · mediastinal tumor · mediastinal tumour · mediastinum neoplasm · mediastinum neoplasm (disease) · mediastinum tumor · mediastinum tumour · neoplasm of mediastinum · neoplasm of the mediastinum · tumor of mediastinum · tumor of the mediastinum · tumour of mediastinum · tumour of the mediastinum

Disease family

This is a subtype of neoplasm of thorax. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumorneoplastic disease or syndromeneoplasmneoplasm of thoraxneoplasm of mediastinum

Related subtypes (10): thoracic benign neoplasm, thoracic cancer, breast neoplasm, lung neoplasm, heart neoplasm, neoplasm of pericardium, neoplasm of chest wall, neoplasm of aortic body, sternal neoplasm, axillary neoplasm

Subtypes (7): mediastinal neural neoplasm, mediastinal granular cell myoblastoma, mediastinal mesenchymal tumor, malignant mediastinum hemangiopericytoma, mediastinal cancer, mediastinal germ cell tumor, benign neoplasm of mediastinum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 16.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified10
PHASE24
PHASE41
PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00199082PHASE4COMPLETEDNewly Diagnosed Mature B-ALL, Burkitt’s Lymphoma and Other High-grade Lymphoma in Adults
NCT03521986PHASE3UNKNOWNPain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS
NCT05672108PHASE2RECRUITINGPhase II Trial of Lung Chemoemobolization
NCT00315211PHASE2TERMINATEDWeekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
NCT02499952PHASE2TERMINATEDPembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
NCT05163509PHASE2UNKNOWNMR-linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor
NCT05267496Not specifiedACTIVE_NOT_RECRUITINGOscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
NCT05682742Not specifiedACTIVE_NOT_RECRUITINGClinical Investigation of the da Vinci Surgical System
NCT06563232Not specifiedNOT_YET_RECRUITING22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions
NCT07012694Not specifiedNOT_YET_RECRUITING22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions
NCT07065604Not specifiedRECRUITINGTubeless VATS for Mediastinal Neoplasm
NCT02220231Not specifiedCOMPLETEDEchocardiographic Evaluation of the Change on Pulmonary Blood Flow and Cardiac Function Induced by Capnothorax During One Lung Ventilation
NCT03214341Not specifiedUNKNOWNAssessment of Mediastinal Masses With Diffusion Weighted MR Imaging
NCT03439696Not specifiedCOMPLETEDNeedlescopic-assisted Uniportal vs Uniportal VATS
NCT03537430Not specifiedCOMPLETEDTotally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor
NCT03613272Not specifiedUNKNOWNThe Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
CYCLOPHOSPHAMIDE ANHYDROUS43
DOXORUBICIN43
BETAMETHASONE41
CYTARABINE41
DEXAMETHASONE41
ETHIODIZED OIL41
ETOPOSIDE PHOSPHATE41
IFOSFAMIDE41
METHOTREXATE41
PREDNISOLONE41
RITUXIMAB41
TOPOTECAN41
VINCRISTINE41
VINDESINE41
CHEMBL42601